Abstract
INTRODUCTION
Due to the rising number of cardiac implantable electronic device placement over the last decades there has been a markedly increase in the rate of lead extraction procedures [1, 2] . The most common indications for transvenous lead extraction (TLE) are systemic-and local-infections, system upgrade, lead failure or venous occlusion [3] [4] [5] .
Because chronically implanted leads develop adhesions to adjacent tissue, manual traction is often insufficient for lead removal. Loosening these fibrotic attachments can result in major complications that include tearing of large veins (e.g. superior vena cava, vena subclavia) and laceration of the right ventricle or right atrium causing pericardial tamponade or haemothorax [6, 7] . Furthermore, these attachments also grow between leads and the tricuspid leaflets. Several studies describe traumatic damage of the tricuspid valve during lead extraction procedures with incidence rates of 3.5-12% [8, 9] . By comparison, tricuspid regurgitation (TR) seems to be a rare complication but can definitely present severe clinical consequences such as right heart failure.
To detach aggressive adhesions safely and therefore reduce the risk of major TLE-associated complications a variety of percutaneous lead removal tools have been developed. The excimer laser system and cutting mechanical sheaths are the most commonly used removal tools, nowadays. Using the high frequency 80 Hz laser sheaths allows for safe and effective extraction of chronically implanted pacemaker (PM), implantable cardioverter defibrillator and cardiac resynchronization-therapy device leads, combining high procedural success with low complication rates [10, 11] .
The aim of this study was to examine the effect of laser lead extraction (LLE) on the development of post-procedure TR. †Presented at the DGTHG Annual Meeting, February 2016, Leipzig, Germany and at the 30th Annual Meeting of the EACTS Annual Meeting 2016, Barcelona, Spain, 1-5 October 2016. ‡The first two authors contributed equally to this study.
METHODS

Patient characteristics
We conducted a single centre retrospective analysis of consecutive patients referred for LLE between January 2012 and August 2015.
(i) Local (29.1%) and (ii) systemic (50.6%) infections were the most common indications for extraction procedures, defined in accordance with the Heart Rhythm Society Expert Consensus document from 2009 [12] :
1. Presence of local inflammation-signs (pocket abscess, skin adherence, chronic draining sinus) at the generator pocket or erosion of a lead or device through the skin. 2. Valvular endocarditis with or without definite involvement of the leads and/or device, occult Gram-positive bacteraemia (not contaminant) or sepsis.
Twenty-one (20.3%) procedures were performed due to noninfectious indications such as venous stenosis/occlusion, device upgrade and lead dysfunction.
Indications for lead extraction are displayed in Table 1 .
Inclusion criteria
Two transthoracic echocardiograms, up to 1 month before the procedure and before discharge, were required for inclusion. All 103 patients had tricuspid valve function evaluated pre-and postoperatively. Additionally, intraprocedural transoesophageal echocardiography (TEE) was performed in all cases. In accordance with international recommendations for evaluation of valvular regurgitation with echocardiography the severity of TR was graded from 0 (none) to 4 (severe) [13] . An increase of at least one grade in TR was defined as a significant change in tricuspid valve function.
Removal techniques
All procedures were performed in a hybrid operating room with patients under general anaesthesia and arterial pressure monitoring. To evaluate the tricuspid valve function and to monitor intraprocedural complications we used transoesophageal 3D echocardiography. All patients were prepared for emergent sternotomy with cardiopulmonary bypass circuit standby. We solely used 80 Hz glide light laser sheaths (Spectranetics Corporation, Colorado Springs, CO, USA) to remove PM and ICD leads, we did not attempt simple traction nor did we employ any other lead extraction tool. LLE was performed as previously described by our group [10] .
The extraction procedures were performed with a single sheath technique. Sheaths sizes were 14 or 16 French.
Statistical analysis
All data were recorded prospectively into a database and analysed with SPSS statistical software version 21 (IBM SPSS Statistics for Windows, Version 21.0. Armonk, NY: IBM Corp.). All continuous variables are expressed as mean ± standard deviation and categorical variables are displayed as numbers and percentages. Student's t-test was used to investigate changes in TR function pre-and postoperatively.
RESULTS
Patients
A total of 103 patients underwent LLE, in all cases tricuspid valve function was examined via TTE pre-and postprocedural. Mean patient age was 65.6 ± 15.4 years (range 18-90) and 77 patients (74.8%) were male. Twenty-seven patients had prior cardiac surgery.
Baseline characteristics of the patients are listed in Table 1 .
Procedural data
We No intraoperative death occurred in any of the patients. The overall complication rate was 2.0%. One major (1.0%) and one minor (1.0%) complication occurred in this patient population. The major complication was one sternotomy, due to lateral perforation of the superior vena cava, which could be sutured without further complications. A pocket haematoma was the minor complication in this series of patients. Table 2 .
Echocardiography findings
None of the 103 patients were observed to have intraprocedural worsening in tricuspid valve function using intraoperative 3D TEE imaging. Two patients (1.9%) experienced mild TR after the procedure (both with tricuspid valve endocarditis). Furthermore 10 patients (9.7%) were found to have TR before LLE that returned to normal valve function after the extraction procedure (Table 3) . Ninety-one patients (88.3%) did not experience any significant change of the tricuspid valve function after LLE. When comparing pre-and postoperative TR in all patients, no statistically significant changes were found (P = 0.19).
DISCUSSION
Published results on TR after lead extraction are limited and somehow conflicting. Incidence and predictors of TR following lead extraction remain unclear. In a study by Franceschi et al. [9] , investigating tricuspid valve function in 208 patients undergoing lead extraction, a new onset of severe TR was observed in 13% of the cases. Compared to lead removal by manual traction only, the use of laser sheaths alone or in combination with lasso catheters was an independent risk factor for TR. Use of laser sheaths was reserved for complex cases with severe adhesions, where manual traction failed. This might be an explanation for the higher incidence of TR after LLE in the more complex cases. Adhesions can be found along the whole lead, including the tricuspid valve and its apparatus and therefore the risk for tricuspid damage is higher, independent from the extraction tool. The authors of the study also conclude, that the role of the laser sheaths in the occurrence of TR was difficult to assess, because laser assisted extraction was only used in the most difficult cases with failure of other extraction modalities.
Nine of the 14 patients with severe TR developed new rightsided heart failure, needing medical (n = 5) or surgical (n = 2) therapy. Two patients even died from right heart failure, showing the potential severe clinical course of a traumatic tricuspid regurgitation. Furthermore, it stresses the importance of adequate medical or surgical therapy of a severe traumatic tricuspid regurgitation, to prevent from subsequent right-heart failure.
Givon et al. [14] reported similar results in a study on TR after interventional lead extraction. The incidence of new TR after lead extraction was 15% (13 patients). In a multivariate analysis, use of mechanical tools as well as younger age were predictors for TR development. However, they did not observe a significant difference in the incidence of right-sided heart failure or death in patients with or without TR during follow-up.
In a study by Coffey et al. [15] incidence of clinically significant increase in TR after transvenous lead extraction was 5.4%. A total of 200 leads were extracted and the mean increase in TR score was only +0.18, making significant worsening of TR a rare condition in this study.
In contrast to the above-mentioned studies, Rodriguez et al. [16] did not find any significant increase in grade of TR after transvenous LLE. In their study including 173 patients, they did not find any change in tricuspid valve function in TEE examination during extraction procedure. A subgroup of 53 patients had complete tricuspid valve investigation with preoperative TTE, intraoperative TEE and postoperative TTE. Compared to preoperative TTE, they found 3 patients having new onset of mild (n = 2) TR or severe (n = 1) TR in postoperative TTE. All patients with worsening of tricuspid function had tricuspid valve endocarditis. Interestingly, they observed a return to normal valve function after LLE in 16 (30%) patients having preoperative TR.
The findings by Rodriguez et al. [16] are in line with our observations. In our group of 103 patients having complete pre-, intraand postoperative tricuspid valve evaluation, no significant worsening of tricuspid valve function was seen after LLE. Only 2 (1.9%) patients had new onset of mild TR after extraction procedure, while improvement of TR grade was observed in 9.7% of patients. These results show, that LLE is a safe method for lead removal. Reasons for these favourable outcomes in the study by Rodriguez et al. and our study might be the consequent use of laser sheaths in all extraction cases. Fibrotic adhesions of the ventricular lead may also include the tricuspid valve and subvalvular apparatus. In contrast to the lead extraction by means of manual traction or dilator sheaths, where some extend of mechanical force is needed, the laser gently dissolves the fibrotic adhesions. The excimer laser energy ablates a ring of tissue in contact with the tip of the laser catheter in a depth of 50 mm. This rather small penetration depth allows for precise debulking of the binding sites and minimizes the risk of damaging surrounding structures like the tricuspid valve. Furthermore, the force and traction, applied to the tricuspid valve and its apparatus is reduced, thereby preventing from traumatic tricuspid damage. Furthermore, modern imaging strategies like 3D-TEE guided LLE used in our study, might help to prevent from tricuspid valve damage. The possibility to demonstrate the precise course of the lead and to depict potential risks like tricuspid leaflet perforation sensitizes the operator to act with enormous caution in those cases, thereby preventing valve injury. Additionally, infective endocarditis with involvement of tricuspid leaflets as well as RV leads can be specifically demonstrated.
In our study, 9.7% of the patients having TR before lead extraction, returned to normal valve function after extraction procedure. The implantation of a right ventricular PM or ICD lead traversing the tricuspid valve always carries a certain risk for lead-induced tricuspid regurgitation (LITR) [17] . LITR can be caused by mechanical or electrical factors. Mechanical factors including lead impingement, adherence, perforation or laceration lead to direct interference with tricuspid leaflet motion and coaptation. Electrical factors triggering TR are delayed RV activation, alteration in RV geometry or RV mechanical dyssynchrony. The prevalence of LITR among PM and ICD patients has been described between 7 and 39% in literature [18] . Extracting the leads, and thereby eliminating the reason for LITR can explain the reduction in grade of TR in 9.7% of our patients.
CONCLUSION
Our echocardiographic findings demonstrate that LLE is not associated with an increase in TR. In contrast, about 10% of the patients with preoperative LITR had a return to normal valve function after LLE. Using laser energy to gently dissolve fibrotic adhesions between the lead and tricuspid valvular apparatus might even prevent from traumatic tricuspid regurgitation by reducing mechanical force and traction, needed for extraction attempts with manual traction, femoral snares or dilator sheaths.
Limitations
Major limitation of this study is the retrospective study design. The disadvantages of a retrospective, non-randomized study, including unknown confounders as well as selection and detection bias, cannot be completely avoided. Furthermore, this study has been a single-centre analysis. Additionally, the lack of a longterm follow-up is a further limitation.
